Home

TCG Opportunity III GP, LLC

CIK 1932445 · last filed 2026-02-12

TCG Opportunity III GP, LLC is a corporate insider who has filed 12 SEC Form 4 insider transactions across 4 companies since 2022. The most recent filing shows the insider sold $24.3M of TNYA on Feb 12, 2026. Across all open-market trades the lifetime net is +$353.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $44.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$44.24M

Companies

4

Total Filings

12

Lifetime Open-Market Net

$353.13M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TNYA 10%+ Owner 4,253,298 $0.75 $3.19M $38.45M 3 2026-02-12
EIKN 10%+ Owner 4,312,139 $9.52 $41.05M $304.96M 1 2026-02-09
SRZNW 10%+ Owner 989,893 $0.01 $6.1K $6.27M 2 2026-01-08
NGM BIOPHARMACEUTICALS INC (NGM) Delisted 10%+ Owner 0 $1.54 $0 $3.45M 6 2024-04-08

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-02-12 TNYA Sell (S) −35,202,320 -$24.34M EDGAR
2026-02-09 EIKN Mixed +45,704,800 $304.96M EDGAR
2026-01-08 SRZNW Buy (P) +105,700 $2.10M EDGAR
2025-12-08 SRZNW Buy (P) +216,900 $4.17M EDGAR
2024-04-08 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Mixed −21,742,413 $0 EDGAR
2024-02-14 TNYA Buy (P) +13,333,332 $60.00M EDGAR
2023-11-17 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +45,262 $31.0K EDGAR
2023-01-19 TNYA Buy (P) +1,110,906 $2.79M EDGAR
2023-01-17 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +10,756 $53.2K EDGAR
2023-01-12 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +618,140 $2.96M EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.